Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07756385
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs. Centurion)University Hospital Sveti DuhRecruitingNot Applicable
NCT07756385Recruiting
Not Applicable
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs....University Hospital Sveti...
NCT07755631
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organization of Southwestern OntarioNot Yet RecruitingNot Applicable
NCT07755631Not Yet Recruiting
Not Applicable
The BASIC-S Feasibility Study for Vascular Risk ReductionAcademic Medical Organiza...
NCT07754825
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic StrokeShanghai Pharmaceuticals Holding Co., LtdNot Yet RecruitingPhase 2
NCT07754825Not Yet Recruiting
Phase 2
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Isch...Shanghai Pharmaceuticals...
NCT07754682
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell LymphomaAssistance Publique - Hôpitaux de ParisNot Yet RecruitingPhase 3
NCT07754682Not Yet Recruiting
Phase 3
Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in...Assistance Publique - Hôp...
NCT07754669
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academy of Physical Education in KatowiceCompletedNot Applicable
NCT07754669Completed
Not Applicable
Priming Using Contrast Training ExerciseThe Jerzy Kukuczka Academ...
NCT07756320
Precure Targeted Accrual and Rapid Growth in Enrollment Trial StudyMayo ClinicEnrolling By Invitation
NCT07756320Enrolling By Invitation
—
Precure Targeted Accrual and Rapid Growth in Enrollment Trial StudyMayo Clinic
NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese AdultsLumos PharmaNot Yet RecruitingPhase 2
NCT07754045Not Yet Recruiting
Phase 2
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutid...Lumos Pharma
NCT07755774
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental Health Outpatient Services: Randomized Controlled Pilot TrialKarolinska InstitutetNot Yet RecruitingNot Applicable
NCT07755774Not Yet Recruiting
Not Applicable
Psychological Treatment for Adolescents With Self-injury Within Intensive Mental...Karolinska Institutet
NCT07754279
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica HoldingCompletedPhase 1
NCT07754279Completed
Phase 1
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy VolunteersMateria Medica Holding
NCT07755956
Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisZhuhai Huahaikang Pharmaceutical Technology Co., Ltd.Not Yet RecruitingPhase 1
NCT07755956Not Yet Recruiting
Phase 1
Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisZhuhai Huahaikang Pharmac...
NCT07756008
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without Pelvic Lymph Node Dissection in Bladder CancerSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07756008Not Yet Recruiting
Phase 2
Bladder-Sparing Treatment With Disitamab Vedotin and Toripalimab With or Without...Sun Yat-Sen Memorial Hosp...
NCT07754942
Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel OcclusionZhongshan Hospital Xiamen UniversityNot Yet Recruiting
NCT07754942Not Yet Recruiting
—
Inflammatory Markers and Prognosis After Cerebral Thrombectomy in Large Vessel O...Zhongshan Hospital Xiamen...
NCT07755748
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response IncentivesCenters for Disease Control and PreventionNot Yet RecruitingNot Applicable
NCT07755748Not Yet Recruiting
Not Applicable
Glaucoma Screening to Enhance At-Risk Californians' Health - Survey Response Inc...Centers for Disease Contr...
NCT07755150
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 DiabetesChendu DIAO Pharmaceutical Group CO., LTD.Not Yet RecruitingPhase 2
NCT07755150Not Yet Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects Wi...Chendu DIAO Pharmaceutica...
NCT07756060
Creatine Supplementation in Pediatric Brain InjurySpaulding Rehabilitation HospitalNot Yet RecruitingNot Applicable
NCT07756060Not Yet Recruiting
Not Applicable
Creatine Supplementation in Pediatric Brain InjurySpaulding Rehabilitation...
NCT07755033
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Multidimensional Health MarkersChinese Medical AssociationNot Yet RecruitingNot Applicable
NCT07755033Not Yet Recruiting
Not Applicable
Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Mult...Chinese Medical Associati...
NCT07754929
E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer SurvivorsUniversidade do PortoRecruitingNot Applicable
NCT07754929Recruiting
Not Applicable
E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Se...Universidade do Porto
NCT07755384
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)Jilin UniversityRecruiting
NCT07755384Recruiting
—
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Trac...Jilin University
NCT07756645
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First Line Treatment of Locally Advanced/Metastatic Non-Small Cell Lung Cancer in Adult ParticipantsAbbVieNot Yet RecruitingPhase 3
NCT07756645Not Yet Recruiting
Phase 3
A Study to Assess Intravenous ABBV-1480 Combined With Chemotherapy Versus Pembro...AbbVie
Result Breakdown
Not yet recruiting14 (70%)
Recruiting3 (15%)
Completed2 (10%)
Enrolling by invitation1 (5%)
not_applicable8 (40%)
Phase 24 (20%)
Not Specified3 (15%)
Phase 32 (10%)
Phase 12 (10%)
Phase 41 (5%)